UncategorizedNeuroSense’s PrimeC shows biomarker shifts in Alzheimer’s trial – Longevity.Technology Empower Meds / October 8, 2025
UncategorizedForm Bio and Cure Rare Disease partner to accelerate genetic medicine – Longevity.Technology Empower Meds / October 8, 2025
UncategorizedTelomir-1 reactivates tumor suppressor genes in prostate cancer models – Longevity.Technology Empower Meds / October 8, 2025
UncategorizedAllegro demonstrates superior shock-absorbing hydrogel for osteoarthritis – Longevity.Technology Empower Meds / October 8, 2025
UncategorizedFractyl Health reports strong preclinical data for gene therapy obesity candidate – Longevity.Technology Empower Meds / October 8, 2025
UncategorizedBlueRock reports positive 36-month results from Parkinson’s cell therapy trial – Longevity.Technology Empower Meds / October 8, 2025
UncategorizedHarness launches MISBA Duo platform, inks research deal with Ono Venture – Longevity.Technology Empower Meds / October 7, 2025
UncategorizedAI-powered gene editing startup lands $555m AstraZeneca deal Empower Meds / October 6, 2025
